Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

Group exhibit in Silay bistro

Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

BY CHRYSEE G. SAMILLANO

Cresline Corsiga, Kon Faustino, Dynalyn Tan, Rose Jemino, Chrysee Samillano,  Archell Belleza, Jorge Cape, Francis Fajardo, Burog Alvarado, Arvin Hervias, Buddy Maridable, Fred Orig, Alden Macazar and Froilan Sagre Jr. (left to right)*

Thirty Negros-based visual artists have gathered for a month-long group exhibit at Otsoy’s Bistro in Silay City titled “Duag sang Paghiliusa” (The Color of Unity), which opened Saturday.

The show was organized by artists Alden Macazar of Silay, Jorge Cape of Talisay, Cresline Corsiga of Bacolod, Pintok Enterprises proprietor Froilan Sagre Jr., and the management of Otsoy’s.

The exhibit aims to promote local talents and boost the tourism industry through visual arts displayed in places like “bistros” in the province of Negros.

Ian Fred Solas was one of the guests of honor at the opening of the group exhibit titled “Duag sg Paghiliusa” at Otsoy’s Bistro in Silay City Saturday*
Negrense visual artist Sony Golez, past president of the Art Association of Bacolod*

Guests of honor were Ian Fred Solas, founder of IF Greenhouse Technologies and Sony Golez, past president of the Art Association of Bacolod- Negros.

The exhibit showcases the works of Alden Macazar, Cresline Corsiga, Jorge Cape, Froilan Sagre Jr., Fred Orig, Noby Juno, Arwin Abindan, Bobbie and Mona Guanzon;

Jay-R Delleva, Archell Belleza, Richard Hulleza, Buddy Maridable, Kon Faustino, Arvin Hervias, Burog Alvarado, J.R. Ledesma, Ramon De los Santos, Francis Fajardo, Steve Maquiling, Darel Javier;

Dynalyn Tan, Joey Gallecanao, Rose Jemino, Juliet Emperado, Rusty Quiatchon, Chrysee Samillano, Jovito “Otay” Hecita, Jan Llegue and JB Maridable.*

ARCHIVES

Read Article by date

April 2024
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 

Get your copy of the Visayan Daily Star everyday!

Avail of the FREE 30-day trial.